Skip to main content
$21.54 -$0.12 (-0.6%)

04:00 PM EDT on 09/29/23

Fresenius Med Care Aktiengesellschaft (NYSE:FMS)

CAPS Rating: No stars

The Company is engaged in the manufacture and sale of products for all forms of kidney dialysis, to health care providers throughout the world, and in providing kidney dialysis treatment and other medical ancillary services.

Current Price $21.54 Mkt Cap $12.0B
Open $21.79 P/E Ratio 20.42
Prev. Close $21.54 Div. (Yield) $0.60 (1.9%)
Daily Range $21.52 - $21.82 Volume 448,965
52-Wk Range $12.79 - $27.72 Avg. Daily Vol. 398,665

Caps

How do you think NYSE:FMS will perform against the market?

Add Stock to CAPS Watchlist

All Players

172 Outperform
5 Underperform
 

All-Star Players

21 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:FMS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

suchasi1 (< 20)
Submitted February 28, 2015

Because all the nervous American money is going to flow to Germany until it all collapses.

TMFEnterprise (64.42)
Submitted June 03, 2017

Won't bet against ted weschler on davita...so I'll take the under on fresenius. Medicare reimbursement will be eroded by bundled payments, so these guys will see their margins squeezed over time. I don't see them having a ton of long-term success.

Recent Community Commentary

Read the most recent pitches from players about FMS.

Recs

1
Member Avatar TMFEnterprise (64.42) Submitted: 6/2/2017 10:35:57 PM : Underperform Start Price: $45.62 NYSE:FMS Score: +128.04

Won't bet against ted weschler on davita...so I'll take the under on fresenius. Medicare reimbursement will be eroded by bundled payments, so these guys will see their margins squeezed over time. I don't see them having a ton of long-term success.

Recs

1
Member Avatar suchasi1 (< 20) Submitted: 2/28/2015 3:03:18 PM : Outperform Start Price: $37.75 NYSE:FMS Score: -145.79

Because all the nervous American money is going to flow to Germany until it all collapses.

Recs

0
Member Avatar TrackFortune2013 (34.25) Submitted: 1/3/2013 3:31:51 PM : Outperform Start Price: $31.57 NYSE:FMS Score: -236.10

Fresenius Medical Care A.G. (NYSE: FMS) was also selected due to it being a dialysis winner here in the U.S. At $35.10, its 52-week range is $31.79 to $39.10 and its market cap is about $21.5 billion. Fresenius yields only 0.9% and its recent adjustment for a 2-for-1 stock split implies an expected upside of roughly 7%.

Leaderboard

Find the members with the highest scoring picks in FMS.

Score Leader

mpc5150

mpc5150 (< 20) Score: +304.60

The Score Leader is the player with the highest score across all their picks in FMS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
mpc5150 < 20 9/30/2009 Underperform 3Y $21.67 -0.69% +303.91% +304.60 0 Comment
Dennyf10 69.17 9/25/2008 6/22/2009 Underperform 1Y $22.21 -3.08% +266.81% +269.89 0 Comment
rebelyell009 < 20 6/11/2008 Underperform 1Y $23.89 -9.90% +229.40% +239.30 0 Comment
rrrobz 93.08 5/15/2008 Underperform 3W $22.98 -6.35% +214.00% +220.35 0 Comment
TMFEnterprise 64.42 6/5/2017 Underperform 5Y $45.62 -52.82% +75.22% +128.04 1 Comment
lathe144 22.41 5/23/2022 Outperform 5Y $29.73 -27.60% +8.82% -36.42 0 Comment
cashsage 99.98 6/1/2021 Outperform 5Y $39.35 -45.30% +1.95% -47.25 0 Comment
AberystwythFool 71.40 10/3/2019 Outperform 5Y $30.54 -29.52% +48.54% -78.06 0 Comment
1055291 < 20 8/26/2019 Outperform 5Y $32.22 -33.19% +48.81% -81.99 0 Comment
MSUalum 22.00 8/20/2018 Outperform 5Y $46.23 -53.44% +49.69% -103.14 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for FMS.